
|Articles|December 1, 2004
Medicare revenue for urologists will drop 14% in 2005
Washington--The Centers for Medicare & Medicaid Services has published its final rule implementing the 2005 Medicare fee schedule, and it's not good news for urologists-especially those who administer cancer drugs in their offices.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












